Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 33.57 Million USD | 135.24% |
| 2022 | 13.12 Million USD | -41.37% |
| 2021 | 22.39 Million USD | 27.69% |
| 2020 | 17.53 Million USD | 10.96% |
| 2019 | 15.8 Million USD | 22.44% |
| 2018 | 12.9 Million USD | 19.97% |
| 2017 | 10.75 Million USD | 82.83% |
| 2016 | 5.88 Million USD | 31.24% |
| 2015 | 4.48 Million USD | 0.65% |
| 2014 | 4.45 Million USD | 4.1% |
| 2013 | 4.28 Million USD | -14.89% |
| 2012 | 5.02 Million USD | -14.61% |
| 2011 | 5.88 Million USD | 10.02% |
| 2010 | 5.35 Million USD | 23.52% |
| 2009 | 4.33 Million USD | 1074.85% |
| 2008 | 368.86 Thousand USD | 45.75% |
| 2007 | 253.08 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.16 Million USD | 19.78% |
| 2024 Q2 | 9.77 Million USD | -2.01% |
| 2023 FY | 30.88 Million USD | 135.24% |
| 2023 Q2 | 8.88 Million USD | 10.91% |
| 2023 Q3 | 8.42 Million USD | -5.09% |
| 2023 Q4 | 8.48 Million USD | 0.65% |
| 2023 Q1 | 8 Million USD | 112.76% |
| 2022 Q4 | 3.76 Million USD | -43.75% |
| 2022 Q3 | 6.69 Million USD | 2.83% |
| 2022 FY | 13.12 Million USD | -41.37% |
| 2022 Q1 | 5.88 Million USD | -11.22% |
| 2022 Q2 | 6.5 Million USD | 10.49% |
| 2021 Q2 | 5.6 Million USD | 21.56% |
| 2021 Q1 | 4.6 Million USD | -8.27% |
| 2021 Q4 | 6.63 Million USD | 19.44% |
| 2021 FY | 22.39 Million USD | 27.69% |
| 2021 Q3 | 5.55 Million USD | -0.82% |
| 2020 Q3 | 4.19 Million USD | 3.05% |
| 2020 FY | 17.53 Million USD | 10.96% |
| 2020 Q2 | 4.07 Million USD | -3.9% |
| 2020 Q4 | 5.02 Million USD | 19.57% |
| 2020 Q1 | 4.24 Million USD | -17.82% |
| 2019 Q4 | 5.16 Million USD | 25.58% |
| 2019 Q1 | 2.95 Million USD | -22.99% |
| 2019 FY | 15.8 Million USD | 22.44% |
| 2019 Q2 | 3.57 Million USD | 20.82% |
| 2019 Q3 | 4.1 Million USD | 14.93% |
| 2018 Q1 | 2.92 Million USD | -12.85% |
| 2018 FY | 12.9 Million USD | 19.97% |
| 2018 Q4 | 3.84 Million USD | 27.91% |
| 2018 Q3 | 3 Million USD | -4.25% |
| 2018 Q2 | 3.13 Million USD | 7.32% |
| 2017 Q2 | 2.94 Million USD | 68.7% |
| 2017 Q1 | 1.74 Million USD | -6.74% |
| 2017 FY | 10.75 Million USD | 82.83% |
| 2017 Q4 | 3.35 Million USD | 23.55% |
| 2017 Q3 | 2.71 Million USD | -7.73% |
| 2016 Q4 | 1.87 Million USD | 26.87% |
| 2016 Q2 | 1.32 Million USD | 8.77% |
| 2016 FY | 5.88 Million USD | 31.24% |
| 2016 Q3 | 1.47 Million USD | 11.34% |
| 2016 Q1 | 1.21 Million USD | 1.13% |
| 2015 FY | 4.48 Million USD | 0.65% |
| 2015 Q4 | 1.2 Million USD | 13.2% |
| 2015 Q3 | 1.06 Million USD | -2.53% |
| 2015 Q2 | 1.09 Million USD | -3.18% |
| 2015 Q1 | 1.12 Million USD | -0.26% |
| 2014 Q1 | 1.11 Million USD | -4.4% |
| 2014 Q2 | 1.16 Million USD | 5.12% |
| 2014 Q3 | 1.04 Million USD | -10.75% |
| 2014 Q4 | 1.12 Million USD | 8.22% |
| 2014 FY | 4.45 Million USD | 4.1% |
| 2013 Q1 | 1.12 Million USD | 2.68% |
| 2013 Q2 | 1.02 Million USD | -9.36% |
| 2013 Q3 | 969.08 Thousand USD | -5.08% |
| 2013 Q4 | 1.16 Million USD | 20.08% |
| 2013 FY | 4.28 Million USD | -14.89% |
| 2012 Q4 | 1.09 Million USD | -6.17% |
| 2012 FY | 5.02 Million USD | -14.61% |
| 2012 Q2 | 1.36 Million USD | -2.89% |
| 2012 Q1 | 1.4 Million USD | -10.05% |
| 2012 Q3 | 1.16 Million USD | -14.1% |
| 2011 FY | 5.88 Million USD | 10.02% |
| 2011 Q4 | 1.55 Million USD | 13.68% |
| 2011 Q2 | 1.46 Million USD | -2.62% |
| 2011 Q1 | 1.49 Million USD | -6.38% |
| 2011 Q3 | 1.37 Million USD | -6.16% |
| 2010 Q4 | 1.6 Million USD | 28.14% |
| 2010 FY | 5.35 Million USD | 23.52% |
| 2010 Q2 | 1.31 Million USD | 10.22% |
| 2010 Q3 | 1.25 Million USD | -4.63% |
| 2010 Q1 | 1.18 Million USD | -4.2% |
| 2009 Q2 | 1.04 Million USD | 5160.53% |
| 2009 FY | 4.33 Million USD | 1074.85% |
| 2009 Q4 | 1.24 Million USD | 19.07% |
| 2009 Q3 | 1.04 Million USD | -0.47% |
| 2009 Q1 | 19.91 Thousand USD | -78.4% |
| 2008 FY | 368.86 Thousand USD | 45.75% |
| 2008 Q2 | 229.39 Thousand USD | 642.58% |
| 2008 Q1 | 30.89 Thousand USD | 525.42% |
| 2008 Q3 | 54.59 Thousand USD | -76.2% |
| 2008 Q4 | 92.18 Thousand USD | 68.85% |
| 2007 FY | 253.08 Thousand USD | 0.0% |
| 2007 Q2 | 192.51 Thousand USD | 0.0% |
| 2007 Q3 | 28.58 Thousand USD | -85.15% |
| 2007 Q4 | 4939.39 USD | -82.72% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -4432.693% |
| IR-Med Inc. | 4.89 Million USD | -585.994% |
| Polarean Imaging plc | 12.24 Million USD | -174.231% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -2442.421% |
| Avitar, Inc. | 3.56 Million USD | -840.536% |
| AVITA Medical, Inc. | 80.77 Million USD | 58.439% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -4675.614% |
| Össur hf. | 396.18 Million USD | 91.526% |
| Zecotek Photonics Inc. | 3.46 Million USD | -869.9% |
| QHSLab, Inc. | 961.65 Thousand USD | -3391.131% |
| Wellstar International, Inc. | 1.79 Million USD | -1770.655% |
| Össur hf. | 396.18 Million USD | 91.526% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | -54.158% |
| Escalon Medical Corp. | 5.25 Million USD | -539.396% |
| Aurora Spine Corporation | 8.65 Million USD | -287.786% |
| BrainsWay Ltd. | 28.01 Million USD | -19.825% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | -251.018% |
| Vivos Inc. | 2.78 Million USD | -1104.566% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 96.797% |
| Kelyniam Global, Inc. | 2.27 Million USD | -1375.559% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -3207.958% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -7608.971% |
| Nanomix Corporation | 8.36 Million USD | -301.216% |
| Theraclion SA | 7.43 Million USD | -351.254% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | -2493.321% |
| Positron Corporation | 1 Million USD | -3232.976% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -979.349% |
| Lombard Medical, Inc. | 30.29 Million USD | -10.837% |
| ALR Technologies Inc. | 6.33 Million USD | -429.87% |
| Stratec SE | 46.32 Million USD | 27.521% |
| Vycor Medical, Inc. | 1.27 Million USD | -2532.187% |
| Heart Tronics, Inc. | 14.46 Million USD | -132.174% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -27755.042% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -16164.282% |
| SANUWAVE Health, Inc. | 14.15 Million USD | -137.245% |
| VMS Rehab Systems, Inc. | 63.63 USD | -52762068.788% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -861.139% |
| Ingen Technologies, Inc. | 1.88 Million USD | -1683.668% |
| Odyssey Group International, Inc. | -14.26 Million USD | 335.414% |
| United American Healthcare Corporation | 59 Thousand USD | -56802.658% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -8138.97% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -5189.618% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -1880.022% |
| Urologix, Inc. | 10.09 Million USD | -232.665% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -2557.46% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -464.406% |
| SS Innovations International, Inc. | 21.38 Million USD | -57.015% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -14481.49% |
| Smith & Nephew plc | 3.46 Billion USD | 99.032% |
| NIOX Group Plc | 22.27 Million USD | -50.702% |
| Fuse Medical, Inc. | 10.35 Million USD | -224.372% |
| Broncus Holding Corporation | 38.15 Million USD | 12.001% |
| Brain Scientific Inc. | 9.66 Million USD | -247.444% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -225.855% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -55210.831% |